槲皮素
医学
药理学
疾病
临床试验
动物研究
抗血栓
生物信息学
生物
内科学
抗氧化剂
生物化学
出处
期刊:Current Opinion in Clinical Nutrition and Metabolic Care
[Ovid Technologies (Wolters Kluwer)]
日期:2008-11-01
卷期号:11 (6): 733-740
被引量:424
标识
DOI:10.1097/mco.0b013e32831394b8
摘要
Quercetin is discussed since several decades as a multipotent bioflavonoid with great potential for the prevention and treatment of disease. In the current review, we present the most recent findings on quercetin with regard to the pharmacology, the in-vitro and in-vivo effects in different cell systems and animal models, and the clinical effects in humans.Quercetin bioavailability has been underestimated in the past and can be improved by food matrix components or particular delivery forms. Among the biological effects of particular relevance, the antihypertensive effects of quercetin in humans and the improvement of endothelial function should be emphasized. Together with its antithrombotic and anti-inflammatory effects, the latter mainly mediated through the inhibition of cytokines and nitric oxide, quercetin is a candidate for preventing obesity-related diseases. Most exiting are the findings that quercetin enhances physical power by yet unclear mechanisms. The anti-infectious and immunomodulatory activities of quercetin might be related to this effect.Quercetin is a most promising compound for disease prevention and therapy; however, many of the effects still need confirmation by human intervention trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI